Article Details
Retrieved on: 2023-10-27 20:43:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Polaris Partners, Alexandria Venture Investments, and other investors. Triveni Bio's lead antibody program (TRIV-509) targets kallikreins 5 and 7 ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here